T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.
T3 Pharmaceuticals's investors include Boehringer Ingelheim Venture Fund, Innosuisse, Wille Finance, Reference Capital SA, Swiss Federal Commission for Innovation and Technology.
T3 Pharmaceuticals is headquartered in Basel, Switzerland.
T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.
T3 Pharmaceuticals is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"T3 Pharmaceuticals — Funding & Investors." VCBacked, April 28, 2023, https://www.vcbacked.co/company/t3-pharmaceuticals. Accessed September 30, 2026.
VCBacked. (2023). T3 Pharmaceuticals — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/t3-pharmaceuticals
{{cite web |title=T3 Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/t3-pharmaceuticals |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated